Riverview Capital Advisers’s Stryker SYK Stock Holding History

Riverview Capital Advisers’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$321K	Sell	1,020 -353	-26%	-$111K	0.09%	69
2026 Q1	$451K	Buy	1,373 +3	+0.2%	+$1.08K	0.15%	59
2025 Q4	$482K	Sell	1,370 -2,949	-68%	-$1.07M	0.15%	63
2025 Q3	$1.6M	Hold	4,319	–	–	0.46%	46
2025 Q2	$1.71M	Sell	4,319 -86	-2%	-$32.2K	0.49%	50
2025 Q1	$1.64M	Sell	4,405 -15	-0.3%	-$5.71K	0.52%	47
2024 Q4	$1.59M	Hold	4,420	–	–	0.48%	46
2024 Q3	$1.6M	Hold	4,420	–	–	0.49%	43
2024 Q2	$1.5M	Sell	4,420 -25	-0.6%	-$8.47K	0.51%	41
2024 Q1	$1.59M	Hold	4,445	–	–	0.55%	42
2023 Q4	$1.33M	Buy	4,445 +20	+0.5%	+$5.61K	0.51%	41
2023 Q3	$1.21M	Hold	4,425	–	–	0.54%	43
2023 Q2	$1.35M	Buy	4,425 +4	+0.1%	+$1.16K	0.59%	40
2023 Q1	$1.26M	Hold	4,421	–	–	0.54%	42
2022 Q4	$1.08M	Hold	4,421	–	–	0.58%	43
2022 Q3	$895K	Buy	4,421 +101	+2%	+$21.2K	0.56%	47
2022 Q2	$859K	Hold	4,320	–	–	0.48%	50
2022 Q1	$1.15M	Hold	4,320	–	–	0.53%	46
2021 Q4	$1.16M	Buy	+4,320	New	+$1.13M	0.51%	47

Other funds holding SYK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Riverview Capital Advisers's SYK Position: Q2 2026 in Review

Riverview Capital Advisers reduced its Stryker (SYK) stake by 26% in Q2 2026, selling an estimated $111K and leaving 1,020 shares worth $321K. The position accounts for 0.09% of the portfolio, ranked #69.

Riverview Capital Advisers first reported a position in SYK in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.71M in Q2 2025. 2,263 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

Riverview Capital Advisers held 1,020 shares of Stryker worth $321K as of Q2 2026.
Riverview Capital Advisers sold 353 Stryker shares in Q2 2026, an estimated $111K.
Stryker made up 0.09% of Riverview Capital Advisers's portfolio in Q2 2026, its #69 holding.
Riverview Capital Advisers first reported a position in Stryker in Q4 2021 and has held it in 19 quarters since.
Riverview Capital Advisers's Stryker position peaked at $1.71M in Q2 2025.
2,263 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Riverview Capital Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.